BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Peptide Therapy for Pain Management and Healing Core Medical & Wellness In this video, I discuss the dosage recommendations for BPC 157. Although there are no human clinical trials on optimal dosing, we rely on animal literature and anecdotal evidence. For oral BPC 157 And TB 500: Background, Indications, Efficacy, And Safety GlobalRPH Does BPC 157 Cause Erectile Dysfunction? Evidence and Safe Treatments Bolt Pharmacy The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype